These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36285342)

  • 1. H1N1 G4 swine influenza T cell epitope analysis in swine and human vaccines and circulating strains uncovers potential risk to swine and humans.
    Tan S; Moise L; Pearce DS; Kyriakis CS; Gutiérrez AH; Ross TM; Bahl J; De Groot AS
    Influenza Other Respir Viruses; 2023 Jan; 17(1):e13058. PubMed ID: 36285342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Immunoinformatics Tools for Swine: Designing Epitope-Driven Vaccines, Predicting Vaccine Efficacy, and Making Vaccines on Demand.
    Moise L; Gutiérrez AH; Khan S; Tan S; Ardito M; Martin WD; De Groot AS
    Front Immunol; 2020; 11():563362. PubMed ID: 33123135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell epitope content comparison (EpiCC) of swine H1 influenza A virus hemagglutinin.
    Gutiérrez AH; Rapp-Gabrielson VJ; Terry FE; Loving CL; Moise L; Martin WD; De Groot AS
    Influenza Other Respir Viruses; 2017 Nov; 11(6):531-542. PubMed ID: 29054116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell epitope content comparison (EpiCC) analysis demonstrates a bivalent PCV2 vaccine has greater T cell epitope overlap with field strains than monovalent PCV2 vaccines.
    Bandrick M; Gutiérrez AH; Desai P; Rincon G; Martin WD; Terry FE; De Groot AS; Foss DL
    Vet Immunol Immunopathol; 2020 May; 223():110034. PubMed ID: 32278900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine.
    De Groot AS; Ardito M; McClaine EM; Moise L; Martin WD
    Vaccine; 2009 Sep; 27(42):5740-7. PubMed ID: 19660593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broadly Protective CD8
    Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S
    J Virol; 2021 May; 95(12):. PubMed ID: 33827939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin.
    Wang B; Yu H; Yang FR; Huang M; Ma JH; Tong GZ
    Virol J; 2012 Jun; 9():127. PubMed ID: 22738661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-epitope vaccine provided efficient protection to mice against lethal dose of influenza A virus H1N1.
    Wei H; Lenz SD; Thompson DH; Pogranichniy RM
    Viral Immunol; 2014 Feb; 27(1):14-9. PubMed ID: 24405102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Universal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011.
    Moise L; Terry F; Ardito M; Tassone R; Latimer H; Boyle C; Martin WD; De Groot AS
    Hum Vaccin Immunother; 2013 Jul; 9(7):1598-607. PubMed ID: 23846304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prime-boost concept using a T-cell epitope-driven DNA vaccine followed by a whole virus vaccine effectively protected pigs in the pandemic H1N1 pig challenge model.
    Hewitt JS; Karuppannan AK; Tan S; Gauger P; Halbur PG; Gerber PF; De Groot AS; Moise L; Opriessnig T
    Vaccine; 2019 Jul; 37(31):4302-4309. PubMed ID: 31248687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-vaccine platform development against H1N1 subtype of swine influenza A viruses.
    Wei H; Lenz SD; Thompson DH; Pogranichniy RM
    Viral Immunol; 2012 Aug; 25(4):297-305. PubMed ID: 22816869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the European Avian-like H1N1 swine influenza virus in mice and pigs.
    Ruan BY; Wen F; Gong XQ; Liu XM; Wang Q; Yu LX; Wang SY; Zhang P; Yang HM; Shan TL; Zheng H; Zhou YJ; Tong W; Gao F; Tong GZ; Yu H
    Vet Microbiol; 2018 Aug; 222():75-84. PubMed ID: 30080677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo Validation of Predicted and Conserved T Cell Epitopes in a Swine Influenza Model.
    Gutiérrez AH; Loving C; Moise L; Terry FE; Brockmeier SL; Hughes HR; Martin WD; De Groot AS
    PLoS One; 2016; 11(7):e0159237. PubMed ID: 27411061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic mice.
    Moise L; Tassone R; Latimer H; Terry F; Levitz L; Haran JP; Ross TM; Boyle CM; Martin WD; De Groot AS
    Hum Vaccin Immunother; 2013 Oct; 9(10):2060-8. PubMed ID: 24045788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques.
    Florek KR; Weinfurter JT; Jegaskanda S; Brewoo JN; Powell TD; Young GR; Das SC; Hatta M; Broman KW; Hungnes O; Dudman SG; Kawaoka Y; Kent SJ; Stinchcomb DT; Osorio JE; Friedrich TC
    J Virol; 2014 Nov; 88(22):13418-28. PubMed ID: 25210172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a pandemic (H1N1) 2009 virus vaccine in pigs against the pandemic influenza virus is superior to commercially available swine influenza vaccines.
    Loeffen WL; Stockhofe N; Weesendorp E; van Zoelen-Bos D; Heutink R; Quak S; Goovaerts D; Heldens JG; Maas R; Moormann RJ; Koch G
    Vet Microbiol; 2011 Sep; 152(3-4):304-14. PubMed ID: 21664078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses.
    Grandea AG; Olsen OA; Cox TC; Renshaw M; Hammond PW; Chan-Hui PY; Mitcham JL; Cieplak W; Stewart SM; Grantham ML; Pekosz A; Kiso M; Shinya K; Hatta M; Kawaoka Y; Moyle M
    Proc Natl Acad Sci U S A; 2010 Jul; 107(28):12658-63. PubMed ID: 20615945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope.
    Kim KH; Jung YJ; Lee Y; Park BR; Oh J; Lee YN; Kim MC; Jeeva S; Kang SM
    Virology; 2020 Nov; 550():51-60. PubMed ID: 32882637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Pan-H1 Influenza Vaccine.
    Darricarrère N; Pougatcheva S; Duan X; Rudicell RS; Chou TH; DiNapoli J; Ross TM; Alefantis T; Vogel TU; Kleanthous H; Wei CJ; Nabel GJ
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.